mhurhangee/ep-ind-claims huggingface dataset:
A 5-norbornene-2-spiro-α-cycloalkanone-α'-spiro-2"-5"-norbornene represented by the following general formula: [in the formula, R 1 s, R 2, and R 3 each independently represent one selected from the group consisting of a hydrogen atom, alkyl groups having 1 to 10 carbon atoms, and a fluorine atom, and n represents an integer of 0 to 12].
Assembly for maintaining a lock of a door of a motor vehicle, said assembly comprising: - a clamp ring intended to receive the lock; - a fixing element, - a device for blocking said clamp ring in the door of the motor vehicle, said device comprising a body able to cooperate with the clamp ring and defining a housing for receiving the fixing element with an external thread in order to allow the blocking of the clamp ring in the door, wherein the housing comprises: - a first part with a first diameter; - a second part with a second diameter; the first diameter being higher than the second diameter, the second diameter being shaped for being threaded by the external thread of the fixing element, said fixing element being intended to be inserted in the housing from the first part to the second part, in order to fix the device to the door, - a guiding element being located inside the first part of the housing and projecting towards the interior of the housing, said guiding element enabling the guide of the fixing element from the first part to the second part, wherein the assembly is configured such that after the insertion of the fixing element in the housing of the device, the clamp ring is fixed in the door of the motor vehicle. - a clamp ring intended to receive the lock; - a fixing element, - a device for blocking said clamp ring in the door of the motor vehicle, said device comprising a body able to cooperate with the clamp ring and defining a housing for receiving the fixing element with an external thread in order to allow the blocking of the clamp ring in the door, wherein the housing comprises: - a first part with a first diameter; - a second part with a second diameter; the first diameter being higher than the second diameter, the second diameter being shaped for being threaded by the external thread of the fixing element, said fixing element being intended to be inserted in the housing from the first part to the second part, in order to fix the device to the door, - a guiding element being located inside the first part of the housing and - a first part with a first diameter; - a second part with a second diameter; - a guiding element being located inside the first part of the housing and
An apparatus for use with a surgical dissection instrument having a rotor shaft with an axis of rotation and an alignment member, the apparatus comprising: a drive shaft assembly (2530, 2548) having a first end with a first axis and an opposite second end; an alignment bore formed having sidewalls extending from said first end and extending along the first axis, said alignment bore configured to engage the alignment member of the rotor shaft at least by the alignment member extending into the alignment bore to align said first axis and the axis of rotation; and a drive surface having at least one flat (2550A, B, C) formed adjacent said first end and configured to couple with the rotor shaft, the drive surface being an external drive portion; an adaptor housing surrounding a drive shaft of the drive shaft assembly; a coupling assembly having a rotor shaft with a driving socket, wherein the drive surface is operable to be received within the drive socket of the rotor shaft; a plurality of locking balls positioned in apertures of the rotor shaft such that at least a portion of at least one ball of the plurality of balls engages the drive flat; and a locking ring axially moveable to a position over the plurality of locking balls to affirmatively hold the plurality of locking balls in the drive socket; wherein rotary force is transferred to the drive shaft assembly with the plurality of locking balls from the rotor shaft. a drive shaft assembly (2530, 2548) having a first end with a first axis and an opposite second end; an alignment bore formed having sidewalls extending from said first end and extending along the first axis, said alignment bore configured to engage the alignment member of the rotor shaft at least by the alignment member extending into the alignment bore to align said first axis and the axis of rotation; and a drive surface having at least one flat (2550A, B, C) formed adjacent said first end and configured to couple with the rotor shaft, the drive surface being an external drive portion; an adaptor housing surrounding a drive shaft of the drive shaft assembly; a coupling assembly having a rotor shaft with a driving socket, wherein the drive surface is operable to be received within the drive socket of the rotor shaft; a plurality of locking balls positioned in apertures of the rotor shaft such that at least a portion of at least one ball of the plurality of balls engages the drive flat; and a locking ring axially moveable to a position over the plurality of locking balls to affirmatively hold the plurality of locking balls in the drive socket; wherein rotary force is transferred to the drive shaft assembly with the plurality of locking balls from the rotor shaft.
A method of homogeneous wetting of at least one biopolymer, comprising: mixing at least one biopolymer, ice in microparticular form, and optionally at least one active pharmaceutical ingredient, the mixing occurring by means of mechanical energy input to obtain a homogenous mixture at a temperature below the freezing point of water; further mixing the at least one biopolymer, ice in microparticular form, and optionally the at least one active pharmaceutical ingredient, the mixing occurring along with a steady increase of temperature to above the freezing point of water; and further kneading/mixing to produce a homogeneously wetted biopolymer; wherein the at least one biopolymer is a polysaccharide. mixing at least one biopolymer, ice in microparticular form, and optionally at least one active pharmaceutical ingredient, the mixing occurring by means of mechanical energy input to obtain a homogenous mixture at a temperature below the freezing point of water; further mixing the at least one biopolymer, ice in microparticular form, and optionally the at least one active pharmaceutical ingredient, the mixing occurring along with a steady increase of temperature to above the freezing point of water; and further kneading/mixing to produce a homogeneously wetted biopolymer; wherein the at least one biopolymer is a polysaccharide.
A computer-implemented method, comprising: detecting a violation of a security policy for a device; and occluding, in response to said detecting, a security key included in a security module on the device and configured to be used to decrypt encrypted data for the device, wherein the security key is occluded by encrypting the security key by the security module on the device, wherein the encrypted security key is stored on the device. detecting a violation of a security policy for a device; and occluding, in response to said detecting, a security key included in a security module on the device and configured to be used to decrypt encrypted data for the device, wherein the security key is occluded by encrypting the security key by the security module on the device, wherein the encrypted security key is stored on the device.
A method for producing a black-plated steel sheet by contacting a plated steel sheet with water vapor in a closed vessel, the plated steel sheet including a base steel sheet and a plating layer, the plating layer including a hot-dip Al and Mg-containing Zn-plating layer formed on a surface of the base steel sheet, the method comprising: heating the plated steel sheet disposed in the closed vessel in presence of a first gas having a dew point which is always lower than a temperature of the plated steel sheet; after the heating of the plated steel sheet, reducing a gas pressure in the closed vessel to 70 kPa or less by exhausting a first atmospheric gas heated in the closed vessel; after the reducing of the gas pressure by exhausting the first atmospheric gas, blackening the plating layer by introducing the water vapor into the closed vessel; after the blackening of the plating layer, reducing the gas pressure in the closed vessel to 70 kPa or less by exhausting a second atmospheric gas in the closed vessel where the black-plated steel sheet having the plating layer blackened is disposed; and after the reducing of the gas pressure by exhausting the second atmospheric gas, cooling the plated steel sheet by introducing a second gas having a dew point which is always lower than the temperature of the plated steel sheet into the closed vessel. heating the plated steel sheet disposed in the closed vessel in presence of a first gas having a dew point which is always lower than a temperature of the plated steel sheet; after the heating of the plated steel sheet, reducing a gas pressure in the closed vessel to 70 kPa or less by exhausting a first atmospheric gas heated in the closed vessel; after the reducing of the gas pressure by exhausting the first atmospheric gas, blackening the plating layer by introducing the water vapor into the closed vessel; after the blackening of the plating layer, reducing the gas pressure in the closed vessel to 70 kPa or less by exhausting a second atmospheric gas in the closed vessel where the black-plated steel sheet having the plating layer blackened is disposed; and after the reducing of the gas pressure by exhausting the second atmospheric gas, cooling the plated steel sheet by introducing a second gas having a dew point which is always lower than the temperature of the plated steel sheet into the closed vessel.
A method to be performed by a server (200, 1580), the method comprising: storing information from which it is determinable which unique subset (206,208,210) of M j of N client-identifying keys (202,1512) was assigned to each of one or more provisioned client devices {j}, wherein N and M j are positive integers and M j is less than N; when there is a change in a time modulating value: calculating for each of the N client-identifying keys a hash of a combination comprising the client-identifying key and the modulating value; determining a hash-dependent value (214,1552) for each hash; and associating each hash-dependent value with the client-identifying key from which the corresponding hash was calculated or with an index of the client-identifying key from which the corresponding hash was calculated; receiving a message purporting to identify one of the provisioned client devices {j}; and determining whether the message identifies one of the provisioned client devices {j}. storing information from which it is determinable which unique subset (206,208,210) of M j of N client-identifying keys (202,1512) was assigned to each of one or more provisioned client devices {j}, wherein N and M j are positive integers and M j is less than N; when there is a change in a time modulating value: calculating for each of the N client-identifying keys a hash of a combination comprising the client-identifying key and the modulating value; determining a hash-dependent value (214,1552) for each hash; and associating each hash-dependent value with the client-identifying key from which the corresponding hash was calculated or with an index of the client-identifying key from which the corresponding hash was calculated; calculating for each of the N client-identifying keys a hash of a combination comprising the client-identifying key and the modulating value; determining a hash-dependent value (214,1552) for each hash; and associating each hash-dependent value with the client-identifying key from which the corresponding hash was calculated or with an index of the client-identifying key from which the corresponding hash was calculated; receiving a message purporting to identify one of the provisioned client devices {j}; and determining whether the message identifies one of the provisioned client devices {j}.
A compound of Formula, or a salt, complex, stereoisomer or solvate thereof: wherein: X is a group selected from H, OH, halogen, cyano, NO 2, NH 2, optionally substituted C 1 -C 12 alkyl, optionally substituted amino, optionally substituted amide and optionally substituted aryl; Y is an optionally substituted C 1 -C 12 alkylene group, wherein one or more of the methylene groups in the alkylene group may be further optionally substituted for a group selected from amide, carbonyl, urea and thiourea; m is 0, 1, or 2; and n is 0, 1, or 2. X is a group selected from H, OH, halogen, cyano, NO 2, NH 2, optionally substituted C 1 -C 12 alkyl, optionally substituted amino, optionally substituted amide and optionally substituted aryl; Y is an optionally substituted C 1 -C 12 alkylene group, wherein one or more of the methylene groups in the alkylene group may be further optionally substituted for a group selected from amide, carbonyl, urea and thiourea; m is 0, 1, or 2; and n is 0, 1, or 2.
An information processing system, comprising: a key management unit configured to manage a system key; a storage unit configured to store an encryption data encrypted by the system key; a decision unit configured to make a decision whether or not a processing of the encryption data satisfies a predetermined condition; a virtual execution environment construction unit configured to construct a virtual execution environment protected from a standard execution environment; and a calculation unit configured to perform the processing, wherein the virtual execution environment construction unit constructs the virtual execution environment depending on the decision, the calculation unit includes: a first calculation processor configured to perform the processing in the virtual execution environment; and a second calculation processor configured to perform the processing in the standard execution environment, the first calculation processor performs the processing by decrypting the encryption data based on the system key acquired from the key management unit, the second calculation processor performs the processing without decrypting the encryption data, and the first calculation processor and the second calculation processor perform the processing on the encryption data depending on the decision. a key management unit configured to manage a system key; a storage unit configured to store an encryption data encrypted by the system key; a decision unit configured to make a decision whether or not a processing of the encryption data satisfies a predetermined condition; a virtual execution environment construction unit configured to construct a virtual execution environment protected from a standard execution environment; and a calculation unit configured to perform the processing, wherein the virtual execution environment construction unit constructs the virtual execution environment depending on the decision, the calculation unit includes: a first calculation processor configured to perform the processing in the virtual execution environment; and a second calculation processor configured to perform the processing in the standard execution environment, a first calculation processor configured to perform the processing in the virtual execution environment; and a second calculation processor configured to perform the processing in the standard execution environment, the first calculation processor performs the processing by decrypting the encryption data based on the system key acquired from the key management unit, the second calculation processor performs the processing without decrypting the encryption data, and the first calculation processor and the second calculation processor perform the processing on the encryption data depending on the decision.
A compound of formula A: or a pharmaceutically acceptable salt, solvate, ester, or tautomer thereof, wherein: A is wherein the carbon atom marked with "*" is bonded to the carbon atom to which A is bonded; n is 0, 1, or 2; R 1 is H or OH; R 2 is H or OH; R 3 is C NHR 31, tetrazolyl, or oxadiazolyl, optionally substituted with NHS 2 -(C 1 -C 3) alkyl; R 31 is (CH 2) p OH, or (CH 2) p OSO 3 H; and p is 1 or 2. A is wherein the carbon atom marked with "*" is bonded to the carbon atom to which A is bonded; n is 0, 1, or 2; R 1 is H or OH; R 2 is H or OH; R 3 is C NHR 31, tetrazolyl, or oxadiazolyl, optionally substituted with NHS 2 -(C 1 -C 3) alkyl; R 31 is (CH 2) p OH, or (CH 2) p OSO 3 H; and p is 1 or 2.
A microorganism for producing a mycosporine-like amino acid, wherein an activity of 3-dehydroquinate dehydratase is inactivated as compared to a non-modified microorganism.
A composition for use in the treatment of an animal for a nerve disease or a nerve injury, wherein the composition comprises a myelination enhancing inhibitor which is N-hydroxy-2-(((2-(6-methoxypyridin-3-yl)-4-morpholinothieno[3,2-d]pyrimidin-6-yl)methyl)(methyl)amino)pyrimidine-5-carboxamide (CAS Number 1339928-25-4; CUDC-907), and wherein the nerve disease or nerve injury is selected from: myelopathy, spinal cord injury, myelitis, vascular myelopathy, cervical spondylotic myelopathy, spondylosis, spinal stenosis, demyelinating disease, any disease of the nervous system where the myelin sheath of a neuron is damaged, CNS demyelinating disease, PNS demyelinating disease, genetic demyelinating disease, infectious demyelinating disease, autoimmune demyelinating disease, demyelinating myelinoclastic disease, demyelinating leukodystrophic disease, Devic's disease, CNS neuropathies, diseases resulting in vitamin B12 deficiency, central pontine myelinolysis, myelopathies, tabes dorsalis, leukoencephalopathies, progressive multifocal leukoencephalopathy, leukodystrophies, optic neuritis, transverse myelitis, neuromyelitis optica, Guillain-Barré syndrome, chronic inflammatory demyelinating polyneuropathy, anti-MAG peripheral neuropathy, Charcot-Marie-Tooth disease, Hereditary neuropathy with liability to pressure palsy, copper deficiency associated conditions, peripheral neuropathy, myelopathy, optic neuropathy, progressive inflammatory neuropathy, multiple sclerosis, MS-type clinically isolated syndrome, relapsing-remitting MS, primary progressive MS, secondary progressive MS, traumatic brain injury, acquired brain injury, hypoxic ischemic brain injury, strokes, periventricular leukomalacia, white-matter brain injury, CNS nerve injury, PNS nerve injury, crush nerve injury, and transection nerve injury.
An engine fueled by ammonia, said engine comprising fuel feeding means (7; 56) configured to feed fuel comprised of liquid ammonia in a combustion chamber of the engine and ammonia feeding means (8; 61) configured to feed liquid ammonia in an intake passage of the engine, liquid ammonia fed from the ammonia feeding means (8; 61) into the intake passage, in operation, cooling an intake air, characterized in that an NO x selective reduction catalyst is arranged in an exhaust passage of the engine, said NO x selective reduction catalyst being able to selectively reduce NO x contained in exhaust gas in the presence of ammonia and, in operation, NO x contained in the exhaust gas being reduced by unburnt ammonia exhausted into the exhaust passage in the NO x selective reduction catalyst, and the engine further comprises a control unit configured to control an amount of liquid ammonia which is fed into the intake passage so that an amount of said unburned ammonia becomes an amount able to reduce NO x contained in the exhaust gas by a predetermined setting or more.
A method, comprising: (i) computing voltage stability indices (VSIs) corresponding to a plurality of buses (102, 104, 106, 108, 110, 304, 306) in an electrical power system as a function of phasor values associated with the plurality of buses (102, 104, 106, 108, 110, 304, 306) and a reference phase angle corresponding to one bus of the plurality of buses (102, 104, 106, 108, 110, 304, 306), wherein each of the phasor values comprising one of: voltage magnitude (V m) corresponding to the respective bus, and phase angle (δ m) corresponding to the respective bus, or change or a rate of change of the voltage magnitude (ΔV m) corresponding to the respective bus, and change or a rate of change of the phase angle (Δδ m) corresponding to the respective bus; and wherein the reference phase angle comprises one of a maximum phase angle (δ max) or a minimum phase angle (δ min) determined from the phase angles (δ m) associated with the plurality of buses (102, 104, 106, 108, 110, 304, 306); and (ii) identifying one or more weak buses (102, 104, 106, 108, 110, 304, 306) from the plurality of buses (102, 104, 106, 108, 110, 304, 306) in the electrical power system based on the computed VSIs. (i) computing voltage stability indices (VSIs) corresponding to a plurality of buses (102, 104, 106, 108, 110, 304, 306) in an electrical power system as a function of phasor values associated with the plurality of buses (102, 104, 106, 108, 110, 304, 306) and a reference phase angle corresponding to one bus of the plurality of buses (102, 104, 106, 108, 110, 304, 306), wherein each of the phasor values comprising one of: voltage magnitude (V m) corresponding to the respective bus, and phase angle (δ m) corresponding to the respective bus, or change or a rate of change of the voltage magnitude (ΔV m) corresponding to the respective bus, and change or a rate of change of the phase angle (Δδ m) corresponding to the respective bus; and wherein the reference phase angle comprises one of a maximum phase angle (δ max) or a minimum phase angle (δ min) determined from the phase angles (δ m) associated with the plurality of buses (102, 104, 106, 108, 110, 304, 306); and voltage magnitude (V m) corresponding to the respective bus, and phase angle (δ m) corresponding to the respective bus, or change or a rate of change of the voltage magnitude (ΔV m) corresponding to the respective bus, and change or a rate of change of the phase angle (Δδ m) corresponding to the respective bus; and (ii) identifying one or more weak buses (102, 104, 106, 108, 110, 304, 306) from the plurality of buses (102, 104, 106, 108, 110, 304, 306) in the electrical power system based on the computed VSIs.